Properties of native brain α-synuclein

Nature

Volumn 498, Issue 7453, 2013, Pages

  Burré, Jacqueline ^a   Vivona, Sandro ^a   Diao, Jiajie ^a   Sharma, Manu ^a   Brunger, Axel T ^a   Südhof, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MONOMER; SNARE PROTEIN;

AGGREGATION; BRAIN; DISEASE; PHOSPHOLIPID; PROTEIN;

ARTICLE; BINDING KINETICS; BRAIN FUNCTION; BRAIN LEVEL; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOSOL; DISEASE PREDISPOSITION; ERYTHROCYTE; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS;

EID: 84878994255     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12125     Document Type: Article

References (14)

1. Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of a-Synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449 (1998). (Pubitemid 28183026)
2. Jo, E., McLaurin, J., Yip, C. M., St George-Hyslop, P. & Fraser, P. E. a-Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328-34334 (2000).
3. Burré, J. et al. a-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663-1667 (2010).
4. Martin, I., Dawson, V. L. & Dawson, T. M. Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genomics Hum. Genet. 12, 301-325 (2011).
5. Devine, M. J., Gwinn, K., Singleton, A. & Hardy, J. Parkinson's disease and a-synuclein expression. Mov. Disord. 26, 2160-2168 (2011).
6. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. & Lansbury, P. T. Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715 (1996). (Pubitemid 26363912)
7. Kim, J. Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol. Cells 7, 78-83 (1997). (Pubitemid 127484275)
8. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L. & Lee, S. J. Stabilization of partially folded conformation during a-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276, 43495-43498 (2001).
9. Chandra, S., Chen, X., Rizo, J., Jahn, R. & Südhof, T. C. A broken a-helix in folded a-synuclein. J. Biol. Chem. 278, 15313-15318 (2003).
10. Lokappa, S. B. & Ulmer, T. S. a-Synuclein populates both elongated and broken helix states on small unilamellar vesicles. J. Biol. Chem. 286, 21450-21457 (2011).
11. Fauvet, B. et al. a-synuclein in the central nervous system and from erythrocytes, mammalian cells and E. coli exists predominantly as a disordered monomer. J. Biol. Chem. 287, 15345-15364 (2012).
12. Bartels, T., Choi, J. G., Selkoe, D. J. a-Synuclein occursphysiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110 (2011).
13. Maltsev, A. S., Ying, J. & Bax, A. Impact of N-terminal acetylation of a-synuclein on its randomcoil and lipid binding properties. Biochemistry 51, 5004-5013 (2012).
14. Johnson, H. & Eyers, C. E. Analysis of post-translational modifications by LC-MS/ MS. Methods Mol. Biol. 658, 93-108 (2010).